keyword
https://read.qxmd.com/read/38568193/ligand-bias-underlies-differential-signaling-of-multiple-fgfs-via-fgfr1
#1
JOURNAL ARTICLE
Kelly Karl, Nuala Del Piccolo, Taylor Light, Tanaya Roy, Pooja Deduja, Vlad-Constantin Ursachi, Bohumil Fafilek, Pavel Krejci, Kalina Hristova
The differential signaling of multiple FGF ligands through a single fibroblast growth factor (FGF) receptor (FGFR) plays an important role in embryonic development. Here, we use quantitative biophysical tools to uncover the mechanism behind differences in FGFR1c signaling in response to FGF4, FGF8, and FGF9, a process which is relevant for limb bud outgrowth. We find that FGF8 preferentially induces FRS2 phosphorylation and extracellular matrix loss, while FGF4 and FGF9 preferentially induce FGFR1c phosphorylation and cell growth arrest...
April 3, 2024: ELife
https://read.qxmd.com/read/38391921/fgf9-a-potent-mitogen-is-a-new-ligand-for-integrin-%C3%AE-v%C3%AE-3-and-the-fgf9-mutant-defective-in-integrin-binding-acts-as-an-antagonist
#2
JOURNAL ARTICLE
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9 is a potent mitogen and survival factor, but FGF9 protein levels are generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in cancer. However, the mechanism of FGF9 action has not been fully established. Previous studies showed that FGF1 and FGF2 directly bind to integrin αvβ3, and this interaction is critical for signaling functions (FGF-integrin crosstalk). FGF1 and FGF2 mutants defective in integrin binding were defective in signaling, whereas the mutants still bound to FGFR suppressed angiogenesis and tumor growth, indicating that they act as antagonists...
February 7, 2024: Cells
https://read.qxmd.com/read/38378972/hsa_circ_0032389-enhances-proliferation-and-migration-in-pdgf-bb-induced-human-aortic-vascular-smooth-muscle-cells
#3
JOURNAL ARTICLE
Haiyun Qian, Shengwei Ma, Qian Zhou, Chengang Lei
Circular RNA (circRNAs) has been confirmed to participate in atherosclerosis (AS) progression. However, the role and mechanism of hsa_circ_0032389 in AS process still need to be further revealed. This study evaluates the role and mechanism of hsa_circ_0032389 in AS process. Platelet-derived growth factor-BB (PDGF-BB) was used to induce human aortic vascular smooth muscle cells (HA-VSMCs). The expression levels of hsa_circ_0032389, microRNA (miR)-513a-5p, and fibroblast growth factor receptor substrate 2 (FRS2) were examined by quantitative real-time PCR...
February 20, 2024: Cardiovascular Toxicology
https://read.qxmd.com/read/38376663/circ_0004872-deficiency-attenuates-ox-ldl-induced-vascular-smooth-muscle-cell-dysfunction-by-mir-424-5p-dependent-regulation-of-frs2
#4
JOURNAL ARTICLE
Peng Qian, Xuanchao Cao, Qian Zhang, Meihua Gao, Xin Liu, Lijie Yan
Atherosclerosis (AS) is a pivotal pathological basis of cardiovascular and cerebrovascular diseases, and circular RNAs (circRNAs) has been disclosed to exert a vital part in the progression of AS. However, the functions of circ_0004872 in the progression of AS is indistinct. In this context, we aimed to elucidate the role of circ_0004872 and the potential mechanism in AS. The level of circ_0004872, miR-424-5p and fibroblast growth factor receptor substrate 2 (FRS2) was detected using quantitative real-time polymerase chain reaction (qRT-PCR)...
February 20, 2024: Molecular and Cellular Biochemistry
https://read.qxmd.com/read/38328402/mir-338-3p-acts-as-a-tumor-suppressor-in-lung-squamous-cell-carcinoma-by-targeting-fgfr2-frs2
#5
JOURNAL ARTICLE
Xia Shan, Cheng Zhang, Chunyu Li, Xingchen Fan, Guoxin Song, Jingfeng Zhu, Risheng Cao, Xiuwei Zhang, Wei Zhu
BACKGROUND: Lung cancer refers to the occurrence of malignant tumors in the lung, and squamous cell carcinoma is one of the most common pathological types of non-small cell lung cancer. Studies have shown that microRNAs (miRNAs) play an important role in the occurrence, development, early diagnosis, and treatment of lung cancer. This study aimed to explore the role and possible mechanism of MicroRNA-338-3p (miR-338-3p) in lung squamous cell carcinoma (LUSC). METHOD: In this study, we compared 238 LUSC patients with relatively high miR-338-3p expression levels with 238 miR-338-3p expression levels in The Cancer Genome Atlas (TCGA)-LUSC dataset using first-line gene set enrichment analysis (GSEA)...
April 2023: Cancer Pathog Ther
https://read.qxmd.com/read/38326380/activated-fgfr2-signalling-as-a-biomarker-for-selection-of-intrahepatic-cholangiocarcinoma-patients-candidate-to-fgfr-targeted-therapies
#6
JOURNAL ARTICLE
Giovanni Brandi, Valeria Relli, Marzia Deserti, Andrea Palloni, Valentina Indio, Annalisa Astolfi, Salvatore Serravalle, Alessandro Mattiaccio, Francesco Vasuri, Deborah Malvi, Chiara Deiana, Maria Abbondanza Pantaleo, Matteo Cescon, Alessandro Rizzo, Masaru Katoh, Simona Tavolari
FGFR inhibitors have been developed to inhibit FGFR activation and signal transduction; notwithstanding, currently the selection of intrahepatic cholangiocarcinoma (iCCA) patients for these drugs only relies on the detection of FGFR2 genetic alterations (GAs) in tumor tissues or circulating tumor DNAs, without concomitant assessment of FGFR2 signalling status. Accordingly, we performed multi-omic analyses of FGFR2 genes and FGFR2 signalling molecules in the tissue samples from 36 iCCA naïve patients. Gain-of-function FGFR2 GAs were detected in 7 patients, including missense mutations (n = 3; p...
February 7, 2024: Scientific Reports
https://read.qxmd.com/read/38159618/frs2-regulated-by-mir-429-and-mir-206-promotes-angiogenesis-in-osteosarcoma
#7
JOURNAL ARTICLE
Yan Zhu, Ziying Liu, Lili Cao, Gentao Fan, Ronghao Ji, Liming Zhang, Suolang Daji, Hao Zhu, Yicun Wang, Guangxin Zhou
FRS2 has demonstrated oncogenic roles in various malignancies, including liposarcoma and giant cell tumor of bone. However, its role in osteosarcoma remains less understood, and the upstream regulatory molecules influencing FRS2 remain unclear. This study aims to explore the clinical implications and biological function of FRS2 in osteosarcoma, and the potential regulatory microRNAs (miRNAs) governing its expression. Our study indicated significant upregulation of FRS2 in osteosarcoma cells and tissues by Western blotting and immunohistochemical staining...
December 28, 2023: Gene
https://read.qxmd.com/read/38137377/tephrosin-suppresses-the-chemoresistance-of-paclitaxel-resistant-ovarian-cancer-via-inhibition-of-fgfr1-signaling-pathway
#8
JOURNAL ARTICLE
Hee Su Kim, Sowon Bae, Ye Jin Lim, Kyeong A So, Tae Jin Kim, Seunghee Bae, Jae Ho Lee
Ovarian cancer is the leading cause of death among gynecologic cancers. Paclitaxel is used as a standard first-line therapeutic agent for ovarian cancer. However, chemotherapeutic resistance and high recurrence rates are major obstacles to treating ovarian cancer. We have found that tephrosin, a natural rotenoid isoflavonoid, can resensitize paclitaxel-resistant ovarian cancer cells to paclitaxel. Cell viability, immunoblotting, and a flow cytometric analysis showed that a combination treatment made up of paclitaxel and tephrosin induced apoptotic death...
November 27, 2023: Biomedicines
https://read.qxmd.com/read/38076804/fgf9-a-potent-mitogen-is-a-new-ligand-for-integrin-%C3%AE-v%C3%AE-3-and-the-fgf9-mutant-defective-in-integrin-binding-acts-as-an-antagonist
#9
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9 is a potent mitogen and survival factor, but FGF9 protein level is generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in cancer. However, the mechanism of FGF9 action has not been fully established. Previous studies showed that FGF1 and FGF2 directly bind to integrin αvβ3 and this interaction is critical for signaling functions (FGF-integrin crosstalk). FGF1 and FGF2 mutants defective in integrin binding were defective in signaling, whereas the mutants still bound to FGFR, and suppressed angiogenesis and tumor growth, indicating that they act as antagonists...
December 2, 2023: bioRxiv
https://read.qxmd.com/read/37969322/the-comparison-of-commercial-serum-free-media-for-hanwoo-satellite-cell-proliferation-and-the-role-of-fibroblast-growth-factor-2
#10
JOURNAL ARTICLE
In-Sun Yu, Jungseok Choi, Mina K Kim, Min Jung Kim
Fetal bovine serum (FBS), which contains various nutrients, comprises 20% of the growth medium for cell-cultivated meat. However, ethical, cost, and scientific issues, necesitates identification of alternatives. In this study, we investigated commercially manufactured serum-free media capable of culturing Hanwoo satellite cells (HWSCs) to identify constituent proliferation enhancing factors. Six different serum-free media were selected, and the HWSC proliferation rates in these serum-free media were compared with that of control medium supplemented with 20% FBS...
November 2023: Food science of animal resources
https://read.qxmd.com/read/37875162/formyl-peptide-receptor-2-signalling-triggers-aerobic-metabolism-of-glucose-through-nox2-dependent-modulation-of-pyruvate-dehydrogenase-activity
#11
JOURNAL ARTICLE
Tiziana Pecchillo Cimmino, Ester Pagano, Mariano Stornaiuolo, Gabriella Esposito, Rosario Ammendola, Fabio Cattaneo
The human formyl-peptide receptor 2 (FPR2) is activated by an array of ligands. By phospho-proteomic analysis we proved that FPR2 stimulation induces redox-regulated phosphorylation of many proteins involved in cellular metabolic processes. In this study, we investigated metabolic pathways activated in FPR2-stimulated CaLu-6 cells. The results showed an increased concentration of metabolites involved in glucose metabolism, and an enhanced uptake of glucose mediated by GLUT4, the insulin-regulated member of GLUT family...
October 2023: Open Biology
https://read.qxmd.com/read/37777063/wwefficient-improvement-of-the-proliferation-differentiation-and-anti-arthritic-capacity-of-mesenchymal-stem-cells-by-simply-culturing-on-the-immobilized-fgf2-derived-peptide-44-ergvvsikgv-53
#12
JOURNAL ARTICLE
Soo Bin Lee, Ahmed Abdal Dayem, Sebastian Kmiecik, Kyung Min Lim, Dong Sik Seo, Hyeong-Taek Kim, Polash Kumar Biswas, Minjae Do, Deok-Ho Kim, Ssang-Goo Cho
INTRODUCTION: The stem cell microenvironment has been evidenced to robustly affect its biological functions and clinical grade. Natural or synthetic growth factors, especially, are essential for modulating stem cell proliferation, metabolism, and differentiation via the interaction with specific extracellular receptors. Fibroblast growth factor-2 (FGF-2) possesses pleiotropic functions in various tissues and organs. It interacts with the FGF receptor (FGFR) and activates FGFR signaling pathways, which involve numerous biological functions, such as angiogenesis, wound healing, cell proliferation, and differentiation...
September 28, 2023: Journal of Advanced Research
https://read.qxmd.com/read/37686528/igf1r-contributes-to-cell-proliferation-in-alk-mutated-neuroblastoma-with-preference-for-activating-the-pi3k-akt-signaling-pathway
#13
JOURNAL ARTICLE
Jikui Guan, Marcus Borenäs, Junfeng Xiong, Wei-Yun Lai, Ruth H Palmer, Bengt Hallberg
Aberrant activation of anaplastic lymphoma kinase (ALK) by activating point mutation or amplification drives 5-12% of neuroblastoma (NB). Previous work has identified the involvement of the insulin-like growth factor 1 receptor (IGF1R) receptor tyrosine kinase (RTK) in a wide range of cancers. We show here that many NB cell lines exhibit IGF1R activity, and that IGF1R inhibition led to decreased cell proliferation to varying degrees in ALK-driven NB cells. Furthermore, combined inhibition of ALK and IGF1R resulted in synergistic anti-proliferation effects, in particular in ALK -mutated NB cells...
August 25, 2023: Cancers
https://read.qxmd.com/read/37673211/pooled-ctdna-analysis-of-monaleesa-phase-iii-advanced-breast-cancer-trials
#14
JOURNAL ARTICLE
F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, Y-S Lu, A Lteif, T Taran, N Babbar, D Slamon, C L Arteaga
BACKGROUND: The phase III MONALEESA trials tested the efficacy and safety of the CDK4/6 inhibitor ribociclib with different endocrine therapy partners as first- or second-line treatment of HR+/HER2- advanced breast cancer. Using the largest pooled biomarker dataset of the CDK4/6 inhibitor ribociclib in advanced breast cancer to date, we identified potential biomarkers of response to ribociclib. PATIENTS AND METHODS: Baseline circulating tumour DNA from patients in the MONALEESA trials was assessed using next-generation sequencing...
September 4, 2023: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/37660781/inducible-keratinocyte-specific-fgfr2-deficiency-inhibits-uvb-induced-signaling-proliferation-inflammation-and-skin-carcinogenesis
#15
JOURNAL ARTICLE
Megha Thakur, Okkyung Rho, Alok Khandelwal, Cherie-Ann O Nathan, John DiGiovanni
A potential role for fibroblast growth factor receptor-2 (FGFR2) in cutaneous squamous cell carcinoma (cSCC) has been reported. To demonstrate the specific role of FGFR2 in UVB-induced skin carcinogenesis and development of cSCC, we generated a keratinocyte specific, tamoxifen inducible mouse model of FGFR2 deficiency. In this mouse model, topical application of 4-hydroxy-tamoxifen led to the induction of Cre recombinase to delete FGFR2 in epidermal keratinocytes of both male and female transgenic mice. Analysis of epidermal protein lysates isolated from FGFR2 deficient mice exposed to UVB showed significant reductions of phospho-FGFR (pFGFR; Y653/654) and p-FRS2α as well as downstream effectors of mTORC1 signaling...
September 1, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37629034/comprehensive-evaluation-and-transcriptome-analysis-reveal-the-salt-tolerance-mechanism-in-semi-wild-cotton-gossypium-purpurascens
#16
JOURNAL ARTICLE
Zhen Peng, Abdul Rehman, Xiawen Li, Xuran Jiang, Chunyan Tian, Xiaoyang Wang, Hongge Li, Zhenzhen Wang, Shoupu He, Xiongming Du
Elevated salinity significantly threatens cotton growth, particularly during the germination and seedling stages. The utilization of primitive species of Gossypium hirsutum , specifically Gossypium purpurascens , has the potential to facilitate the restoration of genetic diversity that has been depleted due to selective breeding in modern cultivars. This investigation evaluated 45 G. purpurascens varieties and a salt-tolerant cotton variety based on 34 morphological, physiological, and biochemical indicators and comprehensive salt tolerance index values...
August 16, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37595815/effective-fraction-of-gualou-xiebai-banxia-decoction-inhibits-the-apoptosis-of-myocardial-cells-induced-by-ox-ldl-via-fgf21-fgfr1-%C3%AE-klotho-frs2%C3%AE-signal-pathway
#17
JOURNAL ARTICLE
Mengxue Wu, Chaoqun Hu, Teng Sun, Liying Xun, Qitao Zhao
ETHNOPHARMACOLOGICAL RELEVANCE: The Gualou-Xiebai-Banxia decoction (GXBD), a classical traditional Chinese medicine (TCM) formula, has beneficial effects in turbid phlegm obstruction syndrome, a type of coronary heart disease (CHD). However, the underlying mechanism and effective constituents of GXBD remain elusive. Our previous studies have shown that the effective constituents of GXBD may be enriched in the n-butanol fraction (GXB-N) and water fraction (GXB-W), the targets of which remain unknown...
August 16, 2023: Journal of Ethnopharmacology
https://read.qxmd.com/read/37543351/characterization-of-the-folding-and-binding-properties-of-the-ptb-domain-of-frs2-with-phosphorylated-and-unphosphorylated-ligands
#18
JOURNAL ARTICLE
Valeria Pennacchietti, Livia Pagano, Francesca Malagrinò, Awa Diop, Mariana Di Felice, Sara Di Matteo, Lucia Marcocci, Paola Pietrangeli, Angelo Toto, Stefano Gianni
PTB (PhosphoTyrosine Binding) domains are protein domains that exert their function by binding phosphotyrosine residues on other proteins. They are commonly found in a variety of signaling proteins and are important for mediating protein-protein interactions in numerous cellular processes. PTB domains can also exhibit binding to unphosphorylated ligands, suggesting that they have additional binding specificities beyond phosphotyrosine recognition. Structural studies have reported that the PTB domain from FRS2 possesses this peculiar feature, allowing it to interact with both phosphorylated and unphosphorylated ligands, such as TrkB and FGFR1, through different topologies and orientations...
August 3, 2023: Archives of Biochemistry and Biophysics
https://read.qxmd.com/read/37501839/retracted-trim44-promotes-endometrial-carcinoma-progression-by-activating-the-frs2-signalling-pathway
#19
Evidence-Based Complementary And Alternative Medicine
[This retracts the article DOI: 10.1155/2022/6235771.].
2023: Evidence-based Complementary and Alternative Medicine: ECAM
https://read.qxmd.com/read/37458641/expression-of-fibroblast-growth-factor-receptor-substrate-2-frs2-in-primary-retroperitoneal-liposarcoma-and-its-clinical-implications
#20
JOURNAL ARTICLE
W-D Chen, C-L Miao
OBJECTIVE: The aim of this study was to investigate the expression level of fibroblast growth factor receptor substrate 2 (FRS2) in tissues of patients with primary retroperitoneal liposarcoma (PRPLS) and its correlation with recurrence and prognosis. PATIENTS AND METHODS: The pathological specimens, medical records, and follow-up information of patients with PRPLS who underwent radical surgery for the first time in our hospital from January 2013 to December 2016 were retrospectively analyzed...
July 2023: European Review for Medical and Pharmacological Sciences
keyword
keyword
105045
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.